Skip to main content
21+Industry intelligence — not direct nicotine sales
Products

FDA Launches Expedited IND Pilot, Begins Accepting Applications

Summary: The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot.

The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot.

Adults 21+. WINDBAR does not sell nicotine products on this site. Compliance statement.

← Back to Products